In human subjects, the presence of heterozygous truncating mutations in CIC frequently gives rise to ASD and other neurodevelopmental disorders, thereby indicating that abnormalities within the ATXN1-CIC pathway may constitute a pathogenic pathway for ASD (Lu et al. 2017). This evidence concerns the gene ATXN1 and neurodevelopmental disorder.